This is an interesting paper . I have a number of points that you may wish to consider 1 Line use is closely linked to MRSA and reduction in MRSA is a a key healkth system goal . The alignment of the BPT for fistula/avf with the MRSA agenda and with changes to vas surgery training and practice are probably important aspects of context to cite . 2 the BPT for access is based on teh RA/ jioont Socs clinical guidelines and audit results 3 The break even point of 75 moving to 80 % is correct but it isnt correct to state that reaching the target results in BPT payment for the whole programme . This error occurs x 2 . 4 there was much greater coverage of access in the kidney community than of HHD . Access has its own NSF standard . It was the subject of a national audit . Linked to HCAI . Widely considered a key issue for Dx patients . HHD does not have the same high level visible drivers . 5 Units do not submitt reference costs -its the trust or FT . Similarly units do not make surplus . Few operate as semi-independant business units ie they have their budgets set by the trust finance dept . 6 not all people who get ESRD need RRT -some will not benefit from RRT and in them conservative kidney care is the gold standard option . 7 it is not widely agreed that HHD CAN improve outcomes -given the ref cited (18) (19) (20) the word MAY would perhaps be beter . 8 A return of unit baed HD cost of £28 is clearly an error . In fact there was not massive varaince in MHD costs in the reference cost analyses and teh project to focus on refrence cost in Dx narrowed the difference before the BPT was institued ( the time and effort on access BPT again being different froimn the HHD strategy which was more about developing a social movemnent fro change ) . 
REVIEWER

GENERAL COMMENTS
This is an interesting area as a case study of the impact of financial incentives on quality of care. The problem with the study (and the authors acknowledge this) is that it is very small and therefore debatable as to how far any generalizable conclusions can be drawn from it. I wasn't clear from the methodology how many individuals with what backgrounds were interviewed from each case study site were interviewed. Whilst the article is about perceptions it would have benefitted from some analysis of the actual costs and benefits from each of the sites and again this is something the authors themselves note. I think there are more references on the impact of incentives that would provide for a better analytical framework than are provided in the article.
This is an important area for examination but this is a very limited study. The study needs to be widened across a wider range of case study sites to provide for generalizable conclusions. The methodology in terms of particpants/questions posed needs to be more fully elucidated. The literature review/references need to be widened to include a greater range of analysis of financial incentives in healthcare in England to provide for an analytical framework within which the study can be contextualised.
VERSION 1 -AUTHOR RESPONSE
REVIEWERS' COMMENTS AND OUR RESPONSE
"Please include the setting in the title (e.g. ... qualitative study of dialysis care in England)" We have adjusted the title as suggested.
"The aims of the study refer to kidney units in the UK but only kidney units in England were included." This is correct and we have changed UK to England in several places (page 2, page 9).
"This is an interesting study of perceptions of financial incentives in dialysis care. Although relatively few units were involved the number of interviews should be sufficient to provide saturation. It would be helpful to have a description of any differences between the 3 types of unit targeted." In the methods section (page 9) we have added information about the sizes of the units and their history with home haemodialysis.
"Line use is closely linked to MRSA and reduction in MRSA is a key health system goal. The alignment of the BPT for fistula/avf with the MRSA agenda and with changes to vas surgery training and practice are probably important aspects of context to cite." We have added an introduction to vascular access on page 6, including the different ways in which vascular access has been brought to attention in the renal community.
"The BPT for access is based on the RA/ joint Socs clinical guidelines and audit results." We have added a mention of this on page 7 when we introduce the BPT for vascular access. The guidelines and audit are now also mentioned on page 6 in the paragraph introducing vascular access.
"The break-even point of 75 moving to 80% is correct but it isn't correct to state that reaching the target results in BPT payment for the whole programme. This error occurs x 2." This is correct, and we corrected both instances. On page 7 we rephrased it, and on page 16 we removed it and replaced it with another sentence.
"There was much greater coverage of access in the kidney community than of HHD. Access has its own NSF standard. It was the subject of a national audit. Linked to HCAI. Widely considered a key issue for dialysis patients. HHD does not have the same high level visible drivers."
We have highlighted the attention that has been given to vascular access in the renal community in the introduction (page 6).
"Units do not submit reference costs -its the trust or FT. Similarly units do not make surplus. Few operate as semi-independent business units ie they have their budgets set by the trust finance dept." We have changed some words (mainly replacing "unit" with "Trust") and rephrased a couple of key sentences in the results and discussion to make sure that this is clear (pages 10, 14-16).
"not all people who get ESRD need RRT -some will not benefit from RRT and in them conservative kidney care is the gold standard option." We have adjusted this in the introduction (first paragraph on kidney care, page 5).
"it is not widely agreed that HHD CAN improve outcomes -given the ref cited (18) (19) (20) the word MAY would perhaps be better." We changed this to "more physiological and likely to improve outcomes" (page 6).
"A return of unit based HD cost of £28 is clearly an error. In fact there was not massive variance in MHD (maintenance hemodialysis) costs in the reference cost analyses and the project to focus on reference cost in Dx narrowed the difference before the BPT was instituted (the time and effort on access BPT again being different from the HHD strategy which was more about developing a social movement for change)." We looked into these costs again and also consulted this reviewer for further clarification. This reported unit cost for home haemodialysis (not maintenance haemodialysis) was in fact part of a costing exercise in 2007, rather than official reference costs as was our first impression. We have made this clear now in the text (page 14).
Reviewer 2 "This is an important area for examination but this is a very limited study. The study needs to be widened across a wider range of case study sites to provide for generalizable conclusions." We acknowledge the small size of the study and are aware that a small sample cannot be generalised to all the renal units. However, the five case study sites were purposely selected to represent variations in the prevalence of home haemodialysis in geographically distinct locations, and we believe that they provide credible data and insight into the issues involved. We also note that reviewer 1 says that "Although relatively few units were involved the number of interviews should be sufficient to provide saturation."
"The methodology in terms of participants/questions posed needs to be more fully elucidated." We have added more information about both in the methods section (page 9).
"The literature review/references need to be widened to include a greater range of analysis of financial incentives in healthcare in England to provide for an analytical framework within which the study can be contextualised."
We have added two sections in the introduction (page 5) on the evaluations published about Best Practice Tariffs and CQUIN, as well as contextualising our results in the discussion section (page 16 and 17).
